High Quality Abiraterone Acetate CAS 154229-18-2 with Factory Price

Model NO.
99%
Delivery Time
1-3 Days
Shipping
Worldwide
Minimum
10g
Payment
Bitcoin/Wu/Mg/Wire Transfer
Transport Package
Safe and Fast Delivery
Specification
10g, 100g, 1kg, 25kg
Trademark
hupharma
Origin
China
HS Code
2937290090
Production Capacity
20000kg Per Month
Reference Price
$ 0.81 - 0.90
Contact Us

Product Description

High Quality Abiraterone Acetate CAS 154229-18-2 With Factory Price
 
Product Name: Abiraterone acetate
Synonyms: Abiraterone Acotate;Abiraterone Acetate impurity;(3S,8R,9S,10R,13S,14S)-10,13-dimethyl-17-(pyridin-3-yl)-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl acetate;[(3S,8R,9S,10R,13S,14S)-10,13-dimethyl-17-pyridin-3-yl-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate;(3β)-17-(3-pyridinyl) androsta-5,16-dien-3-yl acetate;Abiraterone acetate, >=99%;Abirteroneacetate;ZYTIGA
CAS: 154229-18-2
MF: C26H33NO2
MW: 391.55
EINECS: 620-314-7
Product Categories: Inhibitors;Inhibitor;API;DQM;Final material;Anti-cancer & immunity;Intermediates & Fine Chemicals;Pharmaceuticals;Steroids
Mol File: 154229-18-2.mol
 
 
Abiraterone acetate Chemical Properties
Melting point  127-130°C
Boiling point  506.7±50.0 °C(Predicted)
density  1.14±0.1 g/cm3(Predicted)
storage temp.  -20°C
solubility  Chlor-oform (Slightly), DMSO (Sparingly), Meth-anol (Sparingly)
pka 5.31±0.12(Predicted)
form  powder
color  white to beige
 
Safety Information
WGK Germany  3
RTECS  BV7992100
HS Code  2937290000

Uses
Abiraterone acetate is a novel steroidal inhibitor of human Cytochrome P450 (17α-Hydroxylase-C17,20-lyase): potential agent for the treatment of prostatic cancer.

Uses
Abiraterone acetate was approved by the U.S. Food and Drug Administration (FDA) in April 2011 for the treatment of castrationresistant prostate cancer. The drug, marketed under the trade name Zytiga, was originally discovered by researchers at the Cancer Research UK Centre for Cancer Therapeutics in 1990, developed by Cougar Biotechnology, and ultimately commercialized by Johnson & Johnson after its acquisition of Cougar in 2009. Abiraterone acetate inhibits CYP17A1-an enzyme expressed in testicular, adrenal, and prostatic tumor tissues-which has been implied in the production of test-osterone and the proliferation of such tumor cell lines.

Uses
A novel steroidal inhibitor of human Cytochrome P450(17a-Hydroxylase-C17,20-lyase): potential agent for the treatment of prostatic cancer.

High Quality Abiraterone Acetate CAS 154229-18-2 with Factory Price

High Quality Abiraterone Acetate CAS 154229-18-2 with Factory Price

 

 

Pharmaceutical Intermediate

LEGALIS.IT, 2023